Brief: Zivo Bioscience Inc Announces Receipt Of A Letter From The U.S. Department Of Agriculture's Center For Veterinary Biologics
23/08/2022 12:43
Aug 23 (Reuters) - Zivo Bioscience Inc ZIVO.O :
* ZIVO BIOSCIENCE INC- ANNOUNCED RECEIPT OF A LETTER FROM
THE U.S.
DEPARTMENT OF AGRICULTURE’S (USDA) CENTER FOR VETERINARY
BIOLOGICS
* ZIVO BIOSCIENCE- RECEIPT AFFIRMS AGENCY HAS JURISDICTION
FOR
REVIEWING CO'S NOVEL IMMUNE-MODULATING BIOLOGIC FOR TREATING
COCCIDIOSIS IN BROILER CHICKENS
* ZIVO BIOSCIENCE- CVB VERIFIED CO’S PRODUCT IS OF
BIOLOGICAL
ORIGIN, FUNCTIONS THROUGH IMMUNE-MODULATING MOA THAT HAS NO
DIRECT ANTIMICROBIAL ACTIVITY
* ZIVO BIOSCIENCE- CVB VERIFIED CO’S PRODUCT IS SUBJECT TO
THEIR
REGULATORY REVIEW
* ZIVO BIOSCIENCE INC- IS CURRENTLY CONTINUING ITS ONGOING
DISCUSSIONS WITH A MAJOR ANIMAL HEALTH COMPANY TO POTENTIALLY
LICENSE ITS PRODUCT CANDIDATE
* ZIVO BIOSCIENCE- ONE OF CO’S POTENTIAL STRATEGIC PARTNERS
INTENDS TO BEGIN NEW 42-DAY IN VIVO STUDY OF CO’S NOVEL PRODUCT
FOR TREATING COCCIDIOSIS IN CHICKENS
Source: [ID: https://bit.ly/3QF2xxI]
Further company coverage: ZIVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zivo Bioscience
See all newsBrief: Zivo Bioscience Plans New Study With University Of Delaware To Combat Avian Influenza In Poultry
Brief: Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza
Brief: Zivo Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product
Brief: Zivo Bioscience Announces Reverse Stock Split
Brief: Trial Results Confirm Efficacy Of Zivo Bioscience’S Non-Antibiotic Product Candidate For The Prevention And Treatment Of Coccidiosis In Broiler Chickens